These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21541674)

  • 1. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.
    Dragutinović VV; Radonjić NV; Petronijević ND; Tatić SB; Dimitrijević IB; Radovanović NS; Krivokapić ZV
    Mol Cell Biochem; 2011 Sep; 355(1-2):173-8. PubMed ID: 21541674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
    Emara M; Cheung PY; Grabowski K; Sawicki G; Wozniak M
    Clin Chem Lab Med; 2009; 47(8):993-1000. PubMed ID: 19569980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen and matrix metalloproteinase 2 serum and peritoneal washes concentration in staging and prognosis in colorectal cancer patients.
    Guzel T; Mirowska-Guzel D; Lech G; Wroński M; Iwanowska M; Słodkowski M
    Pol Przegl Chir; 2018 Jun; 90(5):36-43. PubMed ID: 30426942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
    Dranka-Bojarowska D; Lewinski A; Lekstan A; Gajda M; Ciosek J; Mrowiec S
    J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33571962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients.
    Waas ET; Hendriks T; Lomme RM; Wobbes T
    Dis Colon Rectum; 2005 Apr; 48(4):700-10. PubMed ID: 15906450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients.
    Kim SB; Fernandes LC; Saad SS; Matos D
    Int J Biol Markers; 2003; 18(3):182-7. PubMed ID: 14535588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
    Kostova E; Slaninka-Miceska M; Labacevski N; Jakovski K; Trojachanec J; Atanasovska E; Janevski V; Jovanovik R; Janevska V
    Vojnosanit Pregl; 2014 Jan; 71(1):52-9. PubMed ID: 24516991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
    Mroczko B; Groblewska M; Okulczyk B; Kedra B; Szmitkowski M
    Int J Colorectal Dis; 2010 Oct; 25(10):1177-84. PubMed ID: 20556397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
    Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
    Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
    Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
    J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke.
    Huang CS; Chen CY; Huang LK; Wang WS; Yang SH
    PLoS One; 2020; 15(6):e0233687. PubMed ID: 32502149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
    Iarŭmov N; Ignatov A; Viiachki I
    Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma gelatinase activity does not reflect disease activity after operation for colorectal cancer.
    Waas ET; Wobbes T; Lomme RM; Hendriks T
    Oncology; 2005; 68(2-3):256-62. PubMed ID: 16015042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.